Annual financial statements for 2016: aap with fundamental progress in strategy implementation
aap Implantate AG (aap) made fundamental progress in financial year 2016 in its transformation into a focussed trauma co…
aap Implantate AG (aap) made fundamental progress in financial year 2016 in its transformation into a focussed trauma co…
aap Implantate AG (“aap”) announces the market launch of its innovative periprosthetic LOQTEQ® system with the distal la…
aap Implantate AG (“aap”) was able to achieve many of the targets that it set itself for the financial year 2015 and mad…
aap Implantate AG ("aap") signed a notarized share purchase agreement today with a leading European private equity firm…
. - Sales forecast for FY/2016 between EUR 30 million and EUR 34 million - Sales organisation expanded and stronger foc…
aap Implantate AG (XETRA: AAQ.DE) made a successful start to financial year 2015 with significant sales growth. Accordin…
aap Implantate AG aims to continue implementing its growth strategy in financial year 2015. The company plans growth in…
aap Implantate AG (XETRA: AAQ.DE), a developer, manufacturer and distributor of innovative trauma products, announced th…
aap Implantate AG (XETRA: AAQ.DE) generated, according to preliminary figures, sales of EUR 8.6 million in the fourth qu…
aap Implantate AG (XETRA: AAQ.DE) generated, according to preliminary figures, sales of EUR 7.6 million in the third qua…